Expression, purification, and characterization of protective MPT64 antigen protein and identification of its multimers isolated from nontoxic Mycobacterium tuberculosis H37Ra
- 26 May 2011
- journal article
- research article
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 58 (3) , 185-189
Abstract
MPT64, a secreted protein of Mycobacterium tuberculosis (MTB), stimulates the immune reactions within cells and is a protective antigen that is lost by the bacilli Calmette–Guérin (BCG) vaccine during propagation. To minimize the toxicity caused by MTB, we used the MPT64 gene encoded by nontoxic H37Ra MTB to carry out genetic expansion via polymerase chain reaction and gene clone MPT64. The plasmid DNA encoded MPT64 was expressed at 20°C for 22 H, and a large quantity of MPT64 was obtained. In the absence of urea, MPT64 multimers with subunits being covalently connected via disulfide bonds were detected by Western blot showing strong protein–protein interactions, as evidenced by the formation of MPT64 tetramers. Finally, with urea of decreasing concentrations, we refolded MPT64 purified in the presence of urea and determined its secondary structures using circular dichroism. MPT64 was found to contain 2.2% α‐helix, 50.9% β‐sheet, 19.5% turn, and 27.4% random coil. The molecular weight of MPT64 was determined by a matrix‐assisted laser desorption ionization‐time of flight mass spectrometer and found to be 23,497 Da, very close to the theoretical molecular weight of MPT64. The results presented here provide a sound basis for future biochemical and biophysical studies of MPT64 or any other proteins encoded by nontoxic H37Ra MTB.Keywords
This publication has 15 references indexed in Scilit:
- Supplementation with RD antigens enhances the protective efficacy of BCG in tuberculous miceClinical Immunology, 2007
- The Solution Structure of Antigen MPT64 from Mycobacterium tuberculosis Defines a New Family of Beta-Grasp ProteinsJournal of Molecular Biology, 2007
- Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosisProtein Expression and Purification, 2006
- Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infectionVaccine, 2005
- The Hunt for New Tuberculosis Vaccines: Anti-TB Immunity and Rational Design of VaccinesCurrent Pharmaceutical Design, 2001
- Survival of mice infected with Mycobacterium smegmatis containing large DNA fragments from Mycobacterium tuberculosisTubercle and Lung Disease, 1999
- A Mycobacterium tuberculosis operon encoding ESAT=6 and a novel low-molecular-mass culture filtrate protein (CFP-10)Microbiology, 1998
- Superantigens as immunomodulators: recent structural insightsStructure, 1997
- Human T‐Cell Epitopes on the Mycobacterium tuberculosis Secreted Protein MPT64Scandinavian Journal of Immunology, 1996
- NMR structures of phospholipase A2 reveal conformational changes during interfacial activationNature Structural & Molecular Biology, 1995